Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Shah

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: ondansetron for patients with IBS-D and bowel-predominant symptomsEric D Shah
Digestive Diseases and Sciences|December 13, 2023
Concise Commentary: Red Mucosa Is Not Enough-Another Approach to Treating Dyspeptic SymptomsEric D Shah
Digestive Diseases and Sciences|March 17, 2023
Is Evidence of Absence Considered Absence of Evidence? How Negative Studies Inform Shared Decision-MakingEric D Shah
Digestive Diseases and Sciences|February 5, 2022
Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid DiarrheaEric D Shah
The Lancet. Gastroenterology & Hepatology|March 25, 2021
Optimising clinical trial design to manage placebo response in randomised controlled trials of irritable bowel syndromeEric D Shah
Digestive Diseases and Sciences|August 21, 2020
Breath Test or Duodenal Aspirate for Small Intestinal Bacterial Overgrowth: Still No Breath of Fresh AirEric D Shah
Gastroenterology & Hepatology|April 19, 2021
Cost-Effective Treatments for Irritable Bowel SyndromeEric D Shah
Gastroenterology|April 1, 2018
Skills Acquired During My 1-Year AGA Editorial FellowshipEric D Shah
Gastrointestinal Endoscopy|October 17, 2025
Post-endoscopic retrograde cholangiopancreatography pancreatitis appears less common but more costly than once thoughtEric D Shah
Digestive Diseases and Sciences|January 12, 2022
Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel SyndromeEric D Shah
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: ondansetron for patients with IBS-D and bowel-predominant symptomsEric D Shah
Digestive Diseases and Sciences|December 13, 2023
Concise Commentary: Red Mucosa Is Not Enough-Another Approach to Treating Dyspeptic SymptomsEric D Shah
Digestive Diseases and Sciences|March 17, 2023
Is Evidence of Absence Considered Absence of Evidence? How Negative Studies Inform Shared Decision-MakingEric D Shah
Digestive Diseases and Sciences|February 5, 2022
Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid DiarrheaEric D Shah
The Lancet. Gastroenterology & Hepatology|March 25, 2021
Optimising clinical trial design to manage placebo response in randomised controlled trials of irritable bowel syndromeEric D Shah
Digestive Diseases and Sciences|August 21, 2020
Breath Test or Duodenal Aspirate for Small Intestinal Bacterial Overgrowth: Still No Breath of Fresh AirEric D Shah
Gastroenterology & Hepatology|April 19, 2021
Cost-Effective Treatments for Irritable Bowel SyndromeEric D Shah
Gastroenterology|April 1, 2018
Skills Acquired During My 1-Year AGA Editorial FellowshipEric D Shah
Gastrointestinal Endoscopy|October 17, 2025
Post-endoscopic retrograde cholangiopancreatography pancreatitis appears less common but more costly than once thoughtEric D Shah
Digestive Diseases and Sciences|January 12, 2022
Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel SyndromeEric D Shah
Pageof 12